This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thea Samuelle Ornstein and Regulated Synthetic Gene Activation
Introduction
Thea Samuelle Ornstein is an inventor associated with research in synthetic gene regulation. Her listed patent, “Regulated Synthetic Gene Activation Systems,” concerns methods for controlling gene activation.
Latest Patents
Ornstein is credited with 1 patent: “Regulated Synthetic Gene Activation Systems.” The patent is assigned to the United States of America, as represented by the Secretary of the Department of Health and Human Services.
Career Highlights
The patent reflects work on systems designed to regulate synthetic gene activation, an area relevant to biotechnology and genetic research. The available information identifies Ornstein as a woman inventor and does not specify her location or additional career details.
Collaborations
Ornstein’s listed collaborators include Ahmad S. Khalil and Kok Ann Gan, whose work is also associated with the patent.
Conclusion
Thea Samuelle Ornstein’s recorded contribution is a patent on regulated synthetic gene activation, developed in collaboration with Ahmad S. Khalil and Kok Ann Gan and assigned to the U.S. Department of Health and Human Services.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile